Transdermal delivery of diclofenac using water-in-oil microemulsion: Formulation and mechanistic approach of drug skin permeation

Pharmaceutical Development and Technology

Volumn 19, Issue 3, 2014, Pages 373-384

  Thakkar, Priyanka J ^a   Madan, Parshotam ^a   Lin, Senshang ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

Diclofenac; Phase diagrams; Thermodynamic activity; Transdermal delivery; W o microemulsion

Indexed keywords

COSURFACTANT; DICLOFENAC; OIL; WATER;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; CONDUCTANCE; CONTROLLED STUDY; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STABILITY; IN VITRO STUDY; MALE; MICROEMULSION; NONHUMAN; PH; PRIORITY JOURNAL; RAT; SKIN PERMEABILITY; THERMODYNAMICS; THERMOSTABILITY; VISCOSITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; EMULSIONS; MALE; OILS; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SKIN ABSORPTION; VISCOSITY; WATER;

EID: 84899862310     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2013.788658     Document Type: Article

References (25)

1. Sostres C, Gargallo CJ, Arroyo MT, Lanas A. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastreoenterol 2010;24:121-132.
2. Hasan SMF, Ahmed T, Talib N. Pharmacokinetics of diclofenac sodium in normal man. Pakistan J Pharm Sci 2005;18:18-24.
3. Kogan A, Garti N. Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interf 2006;123:369-385.
4. Schaefer H, Redelmeier TE. Skin barrier: principles of percutaneous absorption. 1st ed. Basel, Switzerland: S Karger AG; 1996:10, 21-22, 35-37.
5. Baraf HSB, Gold MS, Petruschke RA, Wieman MS. Tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities. Am J Geriat Pharmacol 2012;10:47-60.
6. Singh P, Roberts MS. Skin permeability and local tissue concentrations of non-steroidal anti-inflammatory drugs after topical application. J Pharmacol Exp Ther 1994;268:144-151.
7. Radermacher J, Jentsch D, Scholl MA, et al. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Brit J Clin Pharmacol 1991;31:537-541.
8. Azeem A, Khan ZI, Aqil M, et al. Microemulsions as a surrogate carrier for dermal drug delivery. Drug Dev Ind Pharm 2009;35: 525-547.
9. Talegaonkar S, Azeem A, Ahmad FJ, et al. Microemulsions: a novel approach to enhanced drug delivery. Recent Pat Drug Del Form 2008;2:238-257.
10. Ghosh PK, Murthy RSR. Microemulsions: a potential drug delivery system. Curr Drug Del 2006;3:167-180.
11. Shafiq-un-Nabi S, Shakeel F, Talegaonkar S, et al. Formulation development and optimization using nanoemulsion technique: a technical note. AAPS Pharm Sci 2007;8:12-17.
12. Shakeel F, Baboota S, Ahuja A, et al. Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J Nanobiotechnol 2008;6:1-11.
13. Benson HAE. Skin structure, function and permeation. In: Watkinson AC, Benson HAE, eds. Topical and transdermal drug delivery: principles and practice. Hoboken (NJ): Wiley; 2011:3-22.
14. Santos SR, Donzella H, Bertoline MA, et al. Simplified micromethod for the HPLC measurement of diclofenac in plasma. Braz J Med Biol Res 1992;25:125-128.
15. Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev 2002;54:S77-S98.
16. Attwood D. Microemulsions. In: Kreuter J, ed. Colloidal drug delivery systems. Frankfurt, Germany: CRC Press; 1994: 31-70.
17. Parmar N, Singla N, Saima A, Kohli K. Study of cosurfactant effect on nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery system. Colloid Surf B 2011;86:327-338.
18. Lawrence MJ, Rees GD. Microemulsion based media as novel drug delivery systems. Adv Drug Deliv Rev 2000;45:89-121.
19. Shakeel F, Ramadan W. Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions. Colloid Surf B 2010;75: 356-362.
20. Azeem A, Rizwan M, Ahmad FJ, et al. Nanoemulsion components screening and selection: a technical note. AAPS Pharm Sci 2009;10: 69-76.
21. Barakat N, Fouad E, Elmedany A. Formulation design of indomethacin-loaded nanoemulsion for transdermal delivery. Pharm Anal Acta 2011;10:1-8.
22. Lawrence MJ. Surfactant systems: microemulsions and vesicles as vehicles for drug delivery. Eur J Drug Metab Pharmacokin 1994;19: 257-269.
23. Solans C, Izquierdo P, Nolla J, et al. Nanoemulsions. Curr Opin Colloid Interf Sci 2005;10:102-110.
24. Zhao X, Liu JP, Zhang X, Li Y. Enhancement of transdermal delivery of theophylline using microemulsion vehicle. Int J Pharm 2006;327:58-64.
25. Rhee Y, Jung-Gyo C, Park E, Chi S. Transdermal delivery of ketoprofen using microemulsions. Int J Pharm 2001;228: 161-170.